Forendo Pharma

Forendo is a clinical-stage pharmaceutical company that develops and commercializes drug-based therapeutics for the treatment of endometriosis.

Business Model:

Revenue: $2.4M

Employees: 11-50

Rankings

Detailed Forendo Pharma Information

Forendo Pharma was acquired by Organon.
The acquisition happend on 2021-11-11.
Details of the transaction were not public

Acquirer

Geographic Data

Forendo Pharma headquarters map

Address: Itainen Pitkakatu 4

City: Turku

State: southern finland

Zip: 20520

Country: FI

Financial Info

Stage:

series unknown

Raised Last:

$6M

Raised Total:

$31M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Forendo is a clinical-stage pharmaceutical company that develops and commercializes drug-based therapeutics for the treatment of endometriosis.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
9/2018 Equity $4.6M Vesalius Biocapital
7/2019 Venture Round $5.6M Sunstone Life Science Ventures
6/2013 Seed $4.7M
3/2018 Debt $3.7M Business Finland
10/2014 Series A $15.2M MS Ventures
Karolinska Development AB
Finnvera
7/2019 Venture Round $0 M Ventures
Novartis Venture Fund
Novo Holdings
Sunstone Life Science Ventures
Vesalius Biocapital Partners
M Ventures
Novartis Venture Fund
Novo Holdings
Sunstone Life Science Ventures
Vesalius Biocapital Partners
6/2013 Series A $0 Karolinska
Karolinska
9/2018 Venture Round $0 Innovestor
Karolinska
M Ventures
Novartis Venture Fund
Novo Holdings
Vesalius Biocapital Partners
Innovestor
Karolinska
M Ventures
Novartis Venture Fund
Novo Holdings
Vesalius Biocapital Partners
10/2014 Series A $0 M Ventures
Novartis Venture Fund
Finnvera Venture Capital
Karolinska
Novo Holdings
M Ventures
Novartis Venture Fund
Finnvera Venture Capital
Karolinska
Novo Holdings
3/2018 Debt Financing 1 $3.7M Business Finland
Business Finland
7/2019 Venture Round 5 $5.6M M Ventures
Novartis Venture Fund
Novo Holdings
Sunstone Life Science Ventures
Vesalius Biocapital Partners
M Ventures
Novartis Venture Fund
Novo Holdings
Sunstone Life Science Ventures
Vesalius Biocapital Partners
9/2018 Venture Round 6 $4.7M Innovestor
Karolinska
M Ventures
Novartis Venture Fund
Novo Holdings
Vesalius Biocapital Partners
Innovestor
Karolinska
M Ventures
Novartis Venture Fund
Novo Holdings
Vesalius Biocapital Partners
3/2018 Debt Financing 1 $3.7M Business Finland
Business Finland
10/2014 Series A 5 $15.2M M Ventures
Novartis Venture Fund
M Ventures
Novartis Venture Fund
6/2013 Series A 1 $1.6M
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research